IWM
RCEL icon

IHT Wealth Management’s Avita Medical RCEL Stock Holding History

IHT Wealth Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Sell
24,600
-500
-2% -$2.16K ﹤0.01% 1211
2026
Q1 		$92.9K Hold
25,100
– – ﹤0.01% 1224
2025
Q4 		$86.6K Sell
25,100
-750
-3% -$2.99K ﹤0.01% 1157
2025
Q3 		$132K Sell
25,850
-2,050
-7% -$10.7K ﹤0.01% 1140
2025
Q2 		$148K Buy
27,900
+500
+2% +$3.64K ﹤0.01% 1114
2025
Q1 		$223K Buy
27,400
+300
+1% +$2.8K 0.01% 977
2024
Q4 		$347K Sell
27,100
-1,000
-4% -$11.8K 0.01% 809
2024
Q3 		$301K Buy
28,100
+5,500
+24% +$51.7K 0.01% 910
2024
Q2 		$179K Buy
+22,600
New +$215K 0.01% 969
2024
Q1 		– Sell
-22,550
Closed -$309K – 1057
2023
Q4 		$309K Buy
+22,550
New +$258K 0.01% 754
2023
Q2 		– Sell
-10,850
Closed -$152K – 1011
2023
Q1 		$152K Buy
+10,850
New +$115K 0.01% 882

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IHT Wealth Management's RCEL Position: Q2 2026 in Review

IHT Wealth Management reduced its Avita Medical (RCEL) stake by 2% in Q2 2026, selling an estimated $2.16K and leaving 24,600 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #1211.

IHT Wealth Management first reported a position in RCEL in Q1 2023 and has held it in 11 quarters since. The position peaked at $347K in Q4 2024. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • IHT Wealth Management held 24,600 shares of Avita Medical worth $102K as of Q2 2026.
  • IHT Wealth Management sold 500 Avita Medical shares in Q2 2026, an estimated $2.16K.
  • Avita Medical made up ﹤0.01% of IHT Wealth Management's portfolio in Q2 2026, its #1211 holding.
  • IHT Wealth Management first reported a position in Avita Medical in Q1 2023 and has held it in 11 quarters since.
  • IHT Wealth Management's Avita Medical position peaked at $347K in Q4 2024.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on IHT Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.